Cefepime
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | + | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1040142/Cv/1'> |
Cefepime is a fourth-generation [[cephalosporin]] antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with cefepime compared with other β-lactam antibiotics. <ref name="a1">PMID:17448937</ref> [https://en.wikipedia.org/wiki/Cefepime Cefepime]. | Cefepime is a fourth-generation [[cephalosporin]] antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with cefepime compared with other β-lactam antibiotics. <ref name="a1">PMID:17448937</ref> [https://en.wikipedia.org/wiki/Cefepime Cefepime]. | ||
Revision as of 08:22, 31 March 2024
| |||||||||||
References
- ↑ Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis. 2007 May;7(5):338-48. PMID:17448937 doi:10.1016/S1473-3099(07)70109-3
